Rein Therapeutics (RNTX) P/E (2017 - 2026)
Rein Therapeutics (RNTX) P/E from Mar 31, 2017 to Jul 21, 2026. The TTM Rein Therapeutics (RNTX) P/E is -0.46. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Rein Therapeutics (RNTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.46 | -22.86% |
| 2025 | -0.60 | -21.61% |
| 2024 | -0.77 | -28.21% |
| 2023 | -1.07 | +194.01% |
| 2022 | -0.36 | -81.32% |
| 2021 | -1.95 | +94.33% |
| 2020 | -1.00 | +87.54% |
| 2019 | -0.53 | -31.79% |
| 2018 | -0.78 | -92.03% |
| 2017 | -9.82 | N/A |
Comparison Rein Therapeutics (RNTX) P/E with competitors
Rein Therapeutics (RNTX) P/E is -0.46.